Xenon Pharmaceuticals Inc (FRA:XP0)
€ 37.4 0 (0%) Market Cap: 2.82 Bil Enterprise Value: 2.19 Bil PE Ratio: 0 PB Ratio: 3.45 GF Score: 49/100

Full Year 2020 Xenon Pharmaceuticals Inc Earnings Call Transcript

Mar 01, 2021 / 09:30PM GMT
Release Date Price: €15.4 (+1.99%)
Operator

Good morning, ladies and gentlemen, and welcome to the Quarter 4 2020 Xenon Pharmaceuticals, Inc. Earnings Conference Call. (Operator Instructions)

As a reminder, this conference is being recorded. I would now like to turn the conference over to your host today, Ms. Jodi Regts. Ma'am, please go ahead.

Jodi Regts
Xenon Pharmaceuticals Inc. - VP of Corporate Affairs & IR

Thank you. Good afternoon, everyone. Thanks for joining us on our call and webcast to discuss our financial and operating results for the year ended December 31, 2020. Joining me on today's call are Dr. Simon Pimstone, Xenon's Chief Executive Officer; Ian Mortimer, Xenon's President and Chief Financial Officer; and Sherry Aulin, Xenon's, Vice President, Finance. As announced in January, this coming June at the time of the company's annual meeting of shareholders, Simon will be transitioning to his new role as Executive Chair of Xenon's Board. At the same time, Ian will be appointed President and CEO, while Sherry will be appointed Chief Financial Officer.

On today's call,

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot